Theravance Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $42.2M | $25.2M | $0 |
| FY2014 | $48.0M | $337.8M | $277.5M |
| FY2015 | $57.1M | $300.1M | $112.7M |
| FY2016 | $289.0M | $639.3M | $344.7M |
| FY2017 | $326.2M | $441.4M | $89.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $42.2M | $25.2M | $0 |
| FY2014 | $48.0M | $337.8M | $277.5M |
| FY2015 | $57.1M | $300.1M | $112.7M |
| FY2016 | $289.0M | $639.3M | $344.7M |
| FY2017 | $326.2M | $441.4M | $89.0M |